Related Experiment Video
Updated: Oct 12, 2025

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
Published on: May 8, 2017
Clots in tuberculosis
B H Ng1, Y L B Andrea2, N A Nuratiqah1
1Pusat Perubatan Universiti Kebangsaan Malaysia, Department of Internal Medicine, Respiratory Unit, Malaysia.
Tuberculosis (TB) patients face risks of venous thromboembolism (VTE), often undetected. Early anticoagulant and anti-TB treatment are crucial for managing TB-associated thrombosis.
Area of Science:
- Internal Medicine
- Infectious Diseases
- Cardiology
Background:
- Tuberculosis (TB) is a prevalent infectious disease.
- Active TB infection can lead to venous and arterial thrombosis, which are frequently underdiagnosed.
- Thrombotic complications in TB patients require increased clinical attention.
Purpose of the Study:
- To highlight the association between tuberculosis and venous thromboembolism (VTE).
- To present cases of incidental TB-associated thrombosis.
- To emphasize the need for vigilance regarding VTE in TB patients.
Main Methods:
- Case report of two patients with incidental TB-associated thrombosis.
- Review of clinical presentation, diagnostic findings, and treatment outcomes.
- Analysis of the relationship between anti-tuberculous therapy (ATT) and VTE.
Main Results:
- Two patients presented with thrombosis in different venous systems, incidentally discovered alongside active TB.
- Both patients responded favorably to combined anticoagulant and anti-tuberculous therapy (ATT).
- The findings underscore the potential for silent VTE in active TB infections.
Conclusions:
- Patients with active tuberculosis are at increased risk for VTE.
- Close monitoring for VTE is essential during the course of ATT.
- A high index of suspicion for silent VTE is critical in managing TB patients.
More Related Videos
09:02An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 17, 2014
10:10A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Venous Thrombosis I: Introduction